Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2026-01-10 @ 4:47 AM
Study NCT ID:
NCT02649361
Status:
COMPLETED
Last Update Posted:
2019-06-05
First Post:
2016-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.